Suppr超能文献

[Current recommendations for the treatment of preeclampsia].

作者信息

Klockenbusch W, Schrepfer F

机构信息

Klinik und Poliklinik fur Frauenheilkunde und Geburtshilfe, Universitätsklinikum Münster, Münster, Deutschland.

出版信息

Gynakol Geburtshilfliche Rundsch. 2007;47(4):209-14. doi: 10.1159/000107261.

Abstract

Low-dose aspirin, but not vitamin C and vitamin E, has small to moderate benefits when used for the prevention of preeclampsia. There is however little to suggest that the course of manifest preeclampsia can be substantially affected by drug treatment. Antihypertensive therapy increases the risk of fetal growth restriction and is only indicated in severe hypertension to reduce the risk of maternal cerebral hemorrhage. Magnesium sulfate is the drug of choice for the prevention and treatment of eclampsia. Volume expansion as well as the use of steroids in preeclamptic patients without HELLP syndrome have failed to show any improvement. Delivery as the only definitive treatment is always beneficial for the mother whereas expectant management is in favor of a premature fetus. Decision-making largely depends on gestational age and severity of the disease.

摘要

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验